Performance of subgrouped proportional reporting ratios in the US food and drug administration (FDA) adverse event reporting system

被引：0
|
作者：
Dauner, Dan [1 ]
Zhang, Rui [1 ]
Adam, Terrence [1 ]
Leal, Eleazar [2 ]
Farley, Joel F. [3 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Univ Minnesota Duluth, Duluth, MN USA
[3] Univ Minnesota, Coll Pharm, Minneapolis, MN USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1284
引用
收藏
页码：598 / 598
页数：1
相关论文
共 50 条
  • [1] Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system
    Dauner, Daniel G.
    Zhang, Rui
    Adam, Terrence J.
    Leal, Eleazar
    Heitlage, Viviene
    Farley, Joel F.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, 22 (07) : 589 - 597
  • [2] US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)
    Thomas J. Moore
    Richard L. Morrow
    Colin R. Dormuth
    Barbara Mintzes
    [J]. Pharmaceutical Medicine, 2020, 34 : 135 - 140
  • [3] US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)
    Moore, Thomas J.
    Morrow, Richard L.
    Dormuth, Colin R.
    Mintzes, Barbara
    [J]. PHARMACEUTICAL MEDICINE, 2020, 34 (02) : 135 - 140
  • [4] Adverse events reported to the US Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
    Dores, Graca M.
    Jason, Christopher
    Niu, Manette T.
    Perez-Vilar, Silvia
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1087 - 1100
  • [5] Profiling Cumulative Proportional Reporting Ratios of Drug-Induced Liver Injury in the FDA Adverse Event Reporting System (FAERS) Database
    Brinker, Allen D.
    Lyndly, Jenna
    Tonning, Joseph
    Moeny, David
    Levine, Jonathan G.
    Avigan, Mark I.
    [J]. DRUG SAFETY, 2013, 36 (12) : 1169 - 1178
  • [6] Profiling Cumulative Proportional Reporting Ratios of Drug-Induced Liver Injury in the FDA Adverse Event Reporting System (FAERS) Database
    Allen D. Brinker
    Jenna Lyndly
    Joseph Tonning
    David Moeny
    Jonathan G. Levine
    Mark I. Avigan
    [J]. Drug Safety, 2013, 36 : 1169 - 1178
  • [7] Empirical estimation of under-reporting in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Alatawi, Yasser M.
    Hansen, Richard A.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 761 - 767
  • [8] Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Rahman, Md. Motiur
    Alatawi, Yasser
    Cheng, Ning
    Qian, Jingjing
    Plotkina, Annya V.
    Peissig, Peggy L.
    Berg, Richard L.
    Page, David
    Hansen, Richard A.
    [J]. EPILEPSY RESEARCH, 2017, 135 : 71 - 78
  • [9] Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Cong Bang Truong
    Durham, Spencer H.
    Qian, Jingjing
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (05) : 603 - 609
  • [10] Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis
    Zhou, Zeyun
    Hultgren, Kyle Emerson
    [J]. JMIR PUBLIC HEALTH AND SURVEILLANCE, 2020, 6 (03): : 144 - 155
12345